The US Food and Drug Administration (FDA) has granted 510(k) clearance for Drawbridge Health’s OneDraw A1C Test System.

The OneDraw A1C Test System aims to collect and stabilise blood and measurement of HbA1c levels to monitor long-term control of blood sugar (glucose) in those with diabetes.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

A healthcare professional (HCP) can use OneDraw to draw blood quickly and comfortably.

Drawbridge Health CEO Lee McCracken said: “Drawbridge Health was founded with the vision and intent to categorically and positively change the nature of blood-based diagnostic testing, improving both the collection process and patient experience.

“Our 510(k) clearance is a critical milestone as we make our founding vision a reality. We look forward to making our novel technology commercially available soon.”

The small, single-use OneDraw Blood Collection Device collects and stabilises a capillary blood sample from the upper arm.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It can be placed on the skin to collect blood gently using tiny lancets with light vacuum suction. The blood sample is then stabilised and contained within a removable cartridge.

A designated certified clinical laboratory performs the OneDraw A1C Test after use of the OneDraw Blood Collection Device.

Additionally, the OneDraw Blood Collection Device optimises the blood collection process for the patient and enables conducting blood sampling anywhere.

The 510(k) clearance for the device comes after the company presented positive clinical trial data.

The data results highlighted a strong correlation in the HbA1c measurement obtained from samples collected using the OneDraw Blood Collection Device and those using venipuncture.